4
Changes in Ownership
Seres Therapeutics, Inc. Filed Acc 0000899243-16-016850
CFO and EVP sold 5,473 shares at $24.07 ($131,735)
- CFO and EVP acquired 5,473 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Shaff Eric D. · CFO and EVP
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-03-28 | Exercise or conversion : show line 1 in the form | +5,473 | $7.79 | $42,635 | 5,473 | D |
| 2016-03-28 | Sale : show line 2 in the form | −5,473 | $24.07 | $131,735 | 0 | D |
| Open-market sales · 5,473 sh · avg $24.07 · $131,735 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2016-03-28 | Exercise or conversion : show line 3 in the form Stock Option (right to buy) | −5,473 | $7.79 | 2024-12-08 | 5,473 | 257,219 | D |
Loading xslF345X03/doc4.xml…